252 related articles for article (PubMed ID: 21343309)
1. Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection.
Montpellier C; Tews BA; Poitrimole J; Rocha-Perugini V; D'Arienzo V; Potel J; Zhang XA; Rubinstein E; Dubuisson J; Cocquerel L
J Biol Chem; 2011 Apr; 286(16):13954-65. PubMed ID: 21343309
[TBL] [Abstract][Full Text] [Related]
2. The CD81 partner EWI-2wint inhibits hepatitis C virus entry.
Rocha-Perugini V; Montpellier C; Delgrange D; Wychowski C; Helle F; Pillez A; Drobecq H; Le Naour F; Charrin S; Levy S; Rubinstein E; Dubuisson J; Cocquerel L
PLoS One; 2008 Apr; 3(4):e1866. PubMed ID: 18382656
[TBL] [Abstract][Full Text] [Related]
3. EWI-2wint promotes CD81 clustering that abrogates Hepatitis C Virus entry.
Potel J; Rassam P; Montpellier C; Kaestner L; Werkmeister E; Tews BA; Couturier C; Popescu CI; Baumert TF; Rubinstein E; Dubuisson J; Milhiet PE; Cocquerel L
Cell Microbiol; 2013 Jul; 15(7):1234-52. PubMed ID: 23351194
[TBL] [Abstract][Full Text] [Related]
4. EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells.
Charrin S; Le Naour F; Labas V; Billard M; Le Caer JP; Emile JF; Petit MA; Boucheix C; Rubinstein E
Biochem J; 2003 Jul; 373(Pt 2):409-21. PubMed ID: 12708969
[TBL] [Abstract][Full Text] [Related]
5. Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface.
Delandre C; Penabaz TR; Passarelli AL; Chapes SK; Clem RJ
Exp Cell Res; 2009 Jul; 315(11):1953-63. PubMed ID: 19328198
[TBL] [Abstract][Full Text] [Related]
6. EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.
Stipp CS; Kolesnikova TV; Hemler ME
J Biol Chem; 2001 Nov; 276(44):40545-54. PubMed ID: 11504738
[TBL] [Abstract][Full Text] [Related]
7. EWI-2wint--a host cell factor inhibiting hepatitis C virus entry.
Schuster C; Baumert TF
J Hepatol; 2009 Jan; 50(1):222-4. PubMed ID: 19019480
[TBL] [Abstract][Full Text] [Related]
8. Implications for tetraspanin-enriched microdomain assembly based on structures of CD9 with EWI-F.
Oosterheert W; Xenaki KT; Neviani V; Pos W; Doulkeridou S; Manshande J; Pearce NM; Kroon-Batenburg LM; Lutz M; van Bergen En Henegouwen PM; Gros P
Life Sci Alliance; 2020 Nov; 3(11):. PubMed ID: 32958604
[TBL] [Abstract][Full Text] [Related]
9. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins.
Sala-Valdés M; Ursa A; Charrin S; Rubinstein E; Hemler ME; Sánchez-Madrid F; Yáñez-Mó M
J Biol Chem; 2006 Jul; 281(28):19665-75. PubMed ID: 16690612
[TBL] [Abstract][Full Text] [Related]
10. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
[TBL] [Abstract][Full Text] [Related]
11. Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation.
Charrin S; Manié S; Oualid M; Billard M; Boucheix C; Rubinstein E
FEBS Lett; 2002 Apr; 516(1-3):139-44. PubMed ID: 11959120
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain.
Yalaoui S; Zougbédé S; Charrin S; Silvie O; Arduise C; Farhati K; Boucheix C; Mazier D; Rubinstein E; Froissard P
PLoS Pathog; 2008 Feb; 4(2):e1000010. PubMed ID: 18389082
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus entry into host cells.
Helle F; Dubuisson J
Cell Mol Life Sci; 2008 Jan; 65(1):100-12. PubMed ID: 17914604
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization.
Yang XH; Kovalenko OV; Kolesnikova TV; Andzelm MM; Rubinstein E; Strominger JL; Hemler ME
J Biol Chem; 2006 May; 281(18):12976-85. PubMed ID: 16537545
[TBL] [Abstract][Full Text] [Related]
15. EWI-2 regulates alpha3beta1 integrin-dependent cell functions on laminin-5.
Stipp CS; Kolesnikova TV; Hemler ME
J Cell Biol; 2003 Dec; 163(5):1167-77. PubMed ID: 14662754
[TBL] [Abstract][Full Text] [Related]
16. CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.
Zhang S; Kodys K; Babcock GJ; Szabo G
Hepatology; 2013 Sep; 58(3):940-9. PubMed ID: 22577054
[TBL] [Abstract][Full Text] [Related]
17. Screening of EWI-2-Derived Peptides for Targeting Tetraspanin CD81 and Their Effect on Cancer Cell Migration.
Suwatthanarak T; Usuba K; Kuroha K; Tanaka M; Okochi M
Biomolecules; 2023 Mar; 13(3):. PubMed ID: 36979448
[TBL] [Abstract][Full Text] [Related]
18. Microscopic clusters feature the composition of biochemical tetraspanin-assemblies and constitute building-blocks of tetraspanin enriched domains.
Schmidt SC; Massenberg A; Homsi Y; Sons D; Lang T
Sci Rep; 2024 Jan; 14(1):2093. PubMed ID: 38267610
[TBL] [Abstract][Full Text] [Related]
19. EWI-2 modulates lymphocyte integrin alpha4beta1 functions.
Kolesnikova TV; Stipp CS; Rao RM; Lane WS; Luscinskas FW; Hemler ME
Blood; 2004 Apr; 103(8):3013-9. PubMed ID: 15070678
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus entry and the tetraspanin CD81.
Farquhar MJ; Harris HJ; McKeating JA
Biochem Soc Trans; 2011 Apr; 39(2):532-6. PubMed ID: 21428934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
